Cholinergic PET imaging in Lewy body dementia

Dr. Anna Goodheart

Instructor in Neurology and Associate Director of the MGH Lewy Body Dementia Unit

Course Directors: Gary Ho, MD, PhD & Richard Krolewski, MD, PhD, Barbara Kelly Changizi, MD 

Learning Objectives:

1. Review the role of the cholinergic system in neurodegenerative diseases

2. Learn about the role(s) of PET imaging as a biomarker in neurodegenerative disease

3. Learn about ongoing research into cholinergic PET as a biomarker of Lewy body dementia

For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at [email protected].

You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.

SYSTEMWIDE ACCESS

Participation instructions:

This session is open to all Mass General Brigham clinical staff

Meeting link: https://partners.zoom.us/j/88601852915

Please make sure your first name, last name and institution are visible when you sign in.
If you are not identifiable as a Mass General Brigham staff, you will not be allowed into the meeting:

This activity is intended for  with Physicians, researchers, affiliated health professions (NP, PA, physical therapists, social workers), residents, medical students with specialties of Neurology.

ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 Credit^TM
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.